Bone Biologics holds annual shareholder meeting
BBLG•Bone Biologics held its annual shareholder meeting on Sept. 28, 2026. Shareholders confirmed four director nominees, ratified Weinberg & Company, P.A. as auditor for 2026 and approved a potential issuance of shares underlying certain warrants tied to a July 7 agreement.
1. Meeting results
Shareholders confirmed four director nominees to serve until the next annual meeting and ratified Weinberg & Company, P.A. as independent auditor for the year ending Dec. 31, 2026. They also approved a potential issuance of common shares underlying certain warrants tied to a July 7, 2026 agreement.
